0001512563-13-000001.txt : 20130501
0001512563-13-000001.hdr.sgml : 20130501
20130501190849
ACCESSION NUMBER: 0001512563-13-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120701
FILED AS OF DATE: 20130501
DATE AS OF CHANGE: 20130501
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ai Bob Yunjun
CENTRAL INDEX KEY: 0001512563
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32674
FILM NUMBER: 13804939
MAIL ADDRESS:
STREET 1: 444 WASHINGTON BLVD
STREET 2: SUITE 3338
CITY: JERSEY CITY
STATE: NJ
ZIP: 07310
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AOXING PHARMACEUTICAL COMPANY, INC.
CENTRAL INDEX KEY: 0001060426
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 650636168
STATE OF INCORPORATION: FL
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 444 WASHINGTON BLVD
STREET 2: SUITE 3338
CITY: JERSEY CITY
STATE: NJ
ZIP: 07310
BUSINESS PHONE: 646-367-1747
MAIL ADDRESS:
STREET 1: 444 WASHINGTON BLVD
STREET 2: SUITE 3338
CITY: JERSEY CITY
STATE: NJ
ZIP: 07310
FORMER COMPANY:
FORMER CONFORMED NAME: CHINA AOXING PHARMACEUTICAL COMPANY, INC.
DATE OF NAME CHANGE: 20060707
FORMER COMPANY:
FORMER CONFORMED NAME: CENTRAL AMERICAN EQUITIES CORP.
DATE OF NAME CHANGE: 20060425
FORMER COMPANY:
FORMER CONFORMED NAME: CENTRAL AMERICAN EQUITIES INC
DATE OF NAME CHANGE: 19980429
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2012-07-01
1
0001060426
AOXING PHARMACEUTICAL COMPANY, INC.
AXN
0001512563
Ai Bob Yunjun
444 WASHINGTON BLVD
SUITE 3338
JERSEY CITY
NJ
07310
0
0
0
1
ex-CFO
This form is filed to report that I ceased to be an officer of the issuer as of July 1, 2012, and have no further filing obligation.
Bob Yunjun Ai
2013-05-01